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Dangkwisoo-San (DS) is an herbal extract that is widely used in traditional Korean medicine to treat traumatic ecchymosis
and pain by promoting blood circulation and relieving blood stasis. However, the eﬀect of DS in cerebrovascular disease has
not been examined experimentally. The protective eﬀects of DS on focal ischemic brain were investigated in a mouse model.
DS stimulated nitric oxide (NO) production in human brain microvascular endothelial cells (HBMECs). DS (10–300μg/mL)
produced a concentration-dependent relaxation in mouse aorta, which was signiﬁcantly attenuated by the nitric oxide synthase
(NOS) inhibitor L-NAME, suggesting that DS causes vasodilation via a NO-dependent mechanism. DS increased resting cerebral
blood ﬂow (CBF), although it caused mild hypotension. To investigate the eﬀect of DS on the acute cerebral injury, C57/BL6J
mice received 90min of middle cerebral artery occlusion followed by 22.5h of reperfusion. DS administered 3 days before arterial
occlusion signiﬁcantlyreduced cerebral infarct size by 53.7% compared with vehicle treatment. However, DS did not reduce brain
infarctioninmicetreated withtherelativelyspeciﬁcendothelialNOS(eNOS)inhibitor,N
5-(1-iminoethyl)-L-ornithine,suggesting
that the neuroprotective eﬀect of DS is primarily endothelium-dependent. This correlated with increased phosphorylation of
eNOS in the brains of DS-treated mice. DS acutely improves CBF in eNOS-dependent vasodilation and reduces infarct size in
focal cerebral ischemia. These data provide causal evidence that DS is cerebroprotective via the eNOS-dependent production of
NO, which ameliorates blood circulation.
1.Introduction
Stroke is the main cause of adult disability and the third
leading cause of death in the world [1]. Despite decades
of intense research, the treatment of acute stroke remains
limited. Therapies that restore cerebral blood ﬂow (CBF)
are eﬃcacious in acute stroke, suggesting that CBF is
a critical determinant of ﬁnal stroke outcome. Endothelium-
derived nitric oxide (NO) regulates CBF and mediates
vascular response and prevents ischemic stroke by increasing
collateral ﬂow to the ischemic area [2, 3]. Thus, conditions
that enhance endothelial NO synthase (eNOS) activity could
have beneﬁcial eﬀects on stroke.
Herbal medicine may be useful for the treatment of
stroke [4]. Traditional Korean medicine is based on natural
plants and has many herbal prescriptions for treating stroke,
but its therapeutic eﬃcacies as well as its mechanisms are
unclear. Dangkwisoo-San (DS) is used in traditional Korean
medicineforthetreatmentoftraumaticecchymosis andpain
by promoting blood circulation and relieving blood stasis.
Traditional Korean medications usually contain many
compounds that aﬀect multiple targets [5, 6]. The combina-
tion of multiple drugs is thought to maximize therapeutic
eﬃcacy by facilitating synergistic actions and preventing
potential adverse eﬀects. DS contains nine species of herbal
plants (Angelicae gigantis Radix, Paeoniae Radix, Linderae2 Evidence-Based Complementary and Alternative Medicine
Radix, Sappan Lignum, Cyperi Rhizoma, Carthami Flos,
Persicae Semen, Cinnamomi Cortex, and Glycyrrhizae Radix
et Rhizoma) that have various pharmacological eﬀects on
the cardiovascular system [7–9]. However, no report has
described the eﬀects of DS on stroke in an animal model.
The present study examined the eﬀects of DS on cerebral
infarct, blood ﬂow, blood pressure, and eNOS signaling
in response to ischemia. To determine the physiological
relevance of eNOS regulation by DS, DS was administered to
control and N5-(1-iminoethyl)-L-ornithine (L-NIO)-treated
mice for 3 days before subjecting them to middle cerebral
artery occlusion. The ﬁndings suggest that DS has vascular
protectiveactionforacutecerebralischemicdamagethrough
an eNOS-dependent mechanism.
2.Methods
2.1. Preparation of DS Extract. DS was purchased from
Kwangmyungdang Natural Pharmaceutical (Ulsan, Korea).
The herbal components were identiﬁed byone of theauthors
(SuInCho).The mixture (60g)ofthenine constituentdried
plants (Table 1) was boiled in 1L of distilled water using an
herb extractor (Dae-Woong, Korea) for 2h. The ﬁnal extract
volume of 200mL was centrifuged, and the supernatant was
evaporated under reduced pressure at low temperature and
lyophilized. The yield of the ﬁnal products was 4.6g.
2.2. Determination of NO Production in Human Brain
Microvascular Endothelial Cells (HBMECs). A membrane-
permeable ﬂuorescent indicatorfor NO (4-amino-5-methyl-
amino-2 ,7 -diﬂuoroﬂuorescein diacetate; DAF-FM; Molec-
ular Probes, Eugene, OR) was utilized to detect DS-induced
changes of the NO production. DAF-FM DA is converted
via a NO-speciﬁc mechanism to an intensely ﬂuorescent
triazole derivative [10]. HBMECs obtained from Applied
CellBiologyResearch Institute(Kirkland,WA)werecultured
in endothelial growth medium-2 (EGM-2) using a MV
BulletKitsystem (Cambrex,Walkersville, MD).Experiments
were performed after 4–6 cell passages. After reaching
subﬂuency, the cells were incubated in endothelial cell basal
medium (EBM, Cambrex) with DS and L-arginine for
10min, and 5μmol/L DAF-FM DA was loaded into the
cells. After incubation at 37◦C for 5min, the cells were
mildly washed twice using phosphate-buﬀered saline (PBS)
to eliminate any interference. The NOS inhibitor, NG-nitro-
L-arginine methyl ester (L-NAME; 100μmol/L) and acetyl-
choline (30μmol/L) were used to validate themeasurements.
FluorescencewasdetectedusinganAxiovert200ﬂuorescence
microscope (Carl Zeiss, Oberkochen, Germany).
2.3. Isolated Vessel Experiments. Male C57BL/6J mice were
killed by decapitation. The thoracic aorta was removed and
immersed in ice-cold modiﬁed Krebs’ solution (compo-
sition, mmol/L: NaCl, 119.0; KCl, 4.7; NaHCO3, 20.0;
MgSO4·7H2O, 1.2; KH2PO4,1 . 2 ;C a C l 2·2H2O, 2.5; glucose,
11; EDTA, 0.027; pH 7.4). The vessels were dissected for fat
and connectivetissues and cut into 1.5–2mm long segments.
The aortic rings were suspended at a tension of 1.3g by
means of two L-shaped stainless steel wires inserted into the
lumen in 10mL organ chambers ﬁlled with Krebs’ solution
maintained at 37◦C and aerated continuously with 95% O2
and 5% CO2. The aortic rings were allowed to equilibrate
for 90min while changing the chamber solution every
15min. After the resting tension of each vascular specimen
was stabilized, sustained and stable contraction of 1.3 ±
0.6g was maintained by adding phenylephrine (1μmoL).
The vasodilatory eﬀect of DS was studied by cumulative
addition of 10, 30, 100, and 300μg/mL DS at the plateau of
the phenylephrine-induced contraction. Finally, endothelial-
dependent relaxation was tested by subsequent application
of acetylcholine (1μmoL). Changes in isometric tension
were computationally recorded using a model FT 0.3 force-
displacement transducer (Grass, Quincy, MA) connected to
a PowerLab ML 118 system 400 (AD Instruments, Medford,
MA). Relaxations were expressed as the percentage of
relaxation of phenylephrine-induced tone.
2.4. General Surgical Preparation. Male C57BL/6J mice
weighing 20–25g were housed under diurnal lighting con-
ditions and allowed food and tap water ad libitum.A l l
animal procedures were in accordance with the institutional
guidelines for animal research and were approved by the
Institutional Animal Care and Use Committee. Anesthesia
was achieved by face mask-delivered isoﬂurane (2% induc-
tion and 1.5% maintenance in 70% nitrous oxide and 30%
O2). The carotid artery and femoral vein were catheterized
for the measurement of mean arterial blood pressure using
a MLT844 physiological pressure transducer (AD Instru-
ments) and the infusion of DS or saline. The depth of
anesthesia was checked by the absence of cardiovascular
changes in response to a tail pinch. Rectal temperature
was kept at 36.5–37.5◦C using a Panlab thermostatically
controlled heating mat (Harvard Apparatus,Holliston, MA).
The data were continuously recorded using a PowerLab data
acquisition and analysis system (AD Instruments) and were
stored in a computer. Mean arterial blood pressure, arterial
blood gases, and pH were measured after a 3-day treatment
of DS (i-Stat System, Abbott Laboratories, Abbott Park, IL).
The physiological parameters were within the normal limits
(Table 2).
2.5. Focal Cerebral Ischemia. Mice were orally administered
with DS (600mg/kg twice per dayfor 3 days) orsaline before
the ischemic insult. Focal cerebral ischemia was induced
by occluding the middle cerebral artery (MCA) by the
intraluminal ﬁlament technique [11, 12]. MCA occlusion
(MCAO) was induced by the advancement of a silicon-
coated 7–0 monoﬁlament in the internal carotid artery.
In all animals, regional cerebral blood ﬂow (rCBF) was
measured using a PeriFlux Laser Doppler System 5000
(Perimed, Stockholm, Sweden) with a ﬂexible probe to
conﬁrm the achievement of consistent and similar levels
of ischemic induction. The ﬁlament was withdrawn 90min
after occlusion, and reperfusion was conﬁrmed using the
laser Doppler apparatus. The surgical wound was sutured,
and mice were allowed to recover from anesthesia. BrainsEvidence-Based Complementary and Alternative Medicine 3
Table 1: Composition of Dangkwisoo-San.
Scientiﬁc name Herbal name Amount (g)
Angelica gigas Nakai Angelicae gigantis Radix 5.625
Paeonia lactiﬂora Pall Paeoniae Radix 3.750
Lindera strichnifolia Fern´ andez-Villar Linderae Radix 3.750
Caesalpinia sappan L. Sappan Lignum 3.750
Cyperus rotundus L. Cyperi Rhizoma 3.750
Carthamus tinctorious L. Carthami Flos 3.000
Prunus persica Batsch Persicae Semen 2.655
Cinnamomum cassia Presl CinnamomiCortex 2.250
Glycyrrhiza uralensis Fisch Glycyrrhizae Radix et Rhizoma 1.875
Total 30.405
Table 2: Physiologicalparameters.
Control (N = 7) DS (N = 7)
MABP 80.6 ±2.28 4 .2 ±2.0
pH 7.32 ± 0.01 7.36 ±0.04
pCO2 41.1 ±2.03 9 .4 ±2.5
pO2 143.8 ±10.5 148.0 ±6.0
Values are mean ± SEM. MABP (mean arterial blood pressure), pO2,a n d
pCO2 are expressed in mmHg.
were removed 24h after MCA occlusion. Cerebral infarct
size was determined on 2,3,5-triphenyltetrazolium chloride-
(TTC-) stained, 2-mm-thick brain sections. Infarction areas
were quantiﬁed with iSolution full image analysis software
(Image & Microscope Technology, Vancouver, Canada). To
account for and eliminate the eﬀects of swelling/edema,
infarction volume was calculated by an indirect measure-
ment by summing the volumes of each section according
to the following formula: contralateral hemisphere (mm3) −
undamaged ipsilateral hemisphere (mm3).
2.6. Rotarod Test. Rotarod has been used to evaluate motor
coordination by testing the ability of mice to remain on
revolving rod [13]. The apparatus consisted of horizontal
rough metal rod of 3cm diameter attached to a motor with
variable speed (Neo ClickCo., kyeonggi-do, Korea). The rate
of rotation was adjusted to allow the normal mice to stay on
itfor5min.Each mousewas givenﬁvetrialsbeforetheactual
reading was taken. The animals staying on revolving rod for
period of 5min before the surgical procedure were selected,
andthetestwasagainperformedafterfocalcerebralischemia
followed by 24h reperfusion.
2.7. Western Blotting. Brain tissues were collected 90min
after induction of ischemia. Proteins were isolated according
to standard techniques, separated by 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, and transferred
onto a nitrocellulose membrane (Amersham Biosciences,
Piscataway, NJ). Immunoblot analysis was performed with
anti-eNOS and anti-phospho-eNOS (pS1177) antibodies
(BD Biosciences, San Jose, CA), anti-Akt and anti-phospho-
Akt(Ser473) antibodies (Cellsignaling, Danvers, MA), anti-
nNOS and anti-iNOS antibodies (Santa Cruz Biotechnology,
SantaCruz,CA)followedbyincubationwithsecondaryanti-
body conjugated with horseradish peroxidase. The intensity
of chemiluminescence was measured using an ImageQuant
LAS 4000 apparatus (GE Healthcare Life Sciences, Uppsala,
Sweden). The membrane was reprobed with an anti-β-actin
antibody (Sigma-Aldrich, St. Louis, MO) as an internal
control.
2.8. Chemicals. Acetylcholine chloride, L-NAME, and phe-
nylephrine hydrochloride were purchased from Sigma-
Aldrich. L-NIO was purchased from Tocris Bioscience (Bris-
tol, UK), and all other chemicals were reagent grade. The
solid form of the extract was dissolved in distilled water.
2.9. Data Analysis. The data were expressed as mean ±
SEM. Statistical comparisons were performed using paired
or unpaired Student’s t-test and one-way analysis of vari-
ance (ANOVA) or two-way ANOVA for repeated measures
followed by Fisher’s protected least signiﬁcant diﬀerencetest.
P<. 05 was considered statistically signiﬁcant.
3.Results
3.1. DS Stimulates NO Production in HBMEC. DAF-FM
DA, a ﬂuorescent NO-sensitive dye, was used to measure
DS-induced NO release in HBMECs. The eﬀect of the
NOS inhibitor, L-NAME, was also assessed to determine
whether the NO increase was attributable to NOS activity-
derived de novo synthesis. NO production was rapid, being
observed within 5min of30μg/mLDSaddition, and reached
a maximum at 10min in HBMECs (data not shown).
TreatmentofHBMECswith30μg/mLDSfor10mininduced
NO production, which was abrogated by pretreatment
with 100μmol/L L-NAME (Figure 1). Similar results were
obtainedinendothelialcellsfrommouse thoracicaorta(data
not shown). This result was consistent with the suggestion
that the increase in NO production after DS treatment was
mediated by increased NOS activity.4 Evidence-Based Complementary and Alternative Medicine
DS Con L-NAME + DS Ach
Figure 1: Eﬀects of DS on NO production in HBMEC. HBMECs were loaded DAF-FM (50μmol/L) with DS (30μg/mL), in the absence or
presence of the NOS inhibitor,L-NAME (100μmol/L).Acetylcholine (Ach,30μmol/L)wasused to validateour measurements.DS increased
NO production, which was abrogated by L-NAME. The scale bar represents 200μm.
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Figure 2: Eﬀects of DS on phenylephrine-induced aortic contraction. (a) Representative tracings showing that cumulative addition of DS
(10, 30, 100, and 300μg/mL; arrows) relaxed mouse aorta in a concentration-dependent manner in vessel segments preconstricted with
phenylephrine (PE, 1μmol/L).(b) Average of data from four preparations showing that incubation with 100μmol/L L-NAME abolished the
DS-mediated relaxation. ∗P<. 05versus control,two-wayANOVA forrepeated measures.Error bars indicate standard errors andare shown
unidirectionally for clarity.
3.2. DS Causes Vasorelaxation in Isolated Mouse Aorta. DS
concentrations of 10–300μg/mL relaxed isolated mouse
aorta in a concentration-dependent manner with a max-
imum value of 30.02 ± 10.39% at a concentration of
300μg/mL. This relaxation was abolished by the NOS
inhibitor L-NAME (100μmol/L) (Figure 2), conﬁrming the
NO-mediated nature.
3.3. Eﬀects of DS on Blood Pressure and Resting CBF.
DS caused mild hypotension (81.5 ± 2.1mmHg versusEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀects of DS on blood pressure and resting CBF. Mean arterial blood pressure (MABP) was measured from the femoral artery
(a) and cerebral blood ﬂow (CBF) was measured within middle cerebral artery branches (b) during intravenous infusion of DS. Values are
expressed as a percent change from baseline immediately before infusion. DS slightly increased resting CBF in a concentration-dependent
manner in the cortex (P>. 05 versus baseline), although it caused mild hypotension. Values are expressed as means ± SEM of ﬁve separate
experiments. ∗P<. 05 versus control.
71±3.2mmHg, in control and 300μg/kg DS group; P<. 05,
N = 5; Figure 3(a)) at a concentration of 300μg/kg when
infused via mouse femoral vein. Resting CBF was increased
in the cortex in mice treated with 100–300μg/kg DS in
a concentration-dependent manner, even DS caused mild
hypotension (Figure 3(b)).
3.4. Protective Actions of DS on Cerebral Ischemic Injury. To
determine whether DS couldprotect against ischemic stroke,
DS was administered to mice for 3 days before MCAO.
DS decreased cerebral infarct volume (167.0 ± 38.2mm 3)
as compared with vehicle treatment (89.7 ± 34.0mm 3;
P<. 05, N = 6; Figures 4(a) and 4(b)). Focal cerebral
ischemiafollowedbyreperfusion producedsigniﬁcantmotor
incoordination (P<. 01, N = 5) in mice measured by
rotarod test as compared to that of sham group animals.
DSmarkedlypreventedischemia-reperfusion inducedmotor
incoordination (P<. 05, N = 5; Figure 4(c)). To examine
the contribution of eNOS signaling to the cerebroprotective
action of DS, an experiment tested the impact of DS on
ischemic injury in mice treated with the relatively speciﬁc
eNOS inhibitor, L-NIO. In contrast to control, DS treatment
failed to reduce infarct volume in L-NIO-treated mice
(Figure 4(b)).
3.5. DS Protects against Ischemic Stroke through eNOS-
Dependent Signaling. To further assess the impact of DS on
eNOS signaling during ischemia, the phosphorylation of Akt
at Ser473 and eNOS at Ser1177 in brain tissues was assessed
by Western blotting. DS treatment promoted Akt and eNOS
phosphorylation in both ischemic and nonischemic regions
of the brain compared with control. However, total Akt,
eNOS,iNOS,andnNOSproteinlevelsdidnotdiﬀerbetween
the DS-treated and control mice (Figure 5).
4.Discussion
DS, an herbal extract, is widely used in traditional Korean
medicine to treat traumatic ecchymosis and pain by promot-
ing bloodcirculationand relievingbloodstasis. However,the
eﬀectofDSincerebrovasculardiseasehasnotbeenexamined
experimentally. The present study provides evidence that
DS protects the brain from acute ischemic injury in a
mouse model of MCAO. DS increased NO production,
which led to vasodilation, improved CBF, and decreased
cerebral infarction size. The cerebroprotective eﬀect of DS
was mediated by eNOS, given that DS had no beneﬁcial
eﬀect on cerebral infarction size in mice treated with L-
NIO. Indeed, phosphorylated eNOS was increased in brain
tissue after DS treatment. The present observations indicate
that DS exerts a cerebroprotective action through an eNOS-
dependent mechanism.
When DS was administered 3 days before subjecting
mice to MCAO, cerebral infarct volume was signiﬁcantly
decreased (Figure 4). However, it is not known whether this
was due to a vasodilator eﬀect on cerebral vessels leading6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: DS reduces cerebral ischemic injury. (a) Representative photographs of coronal brain sections stained with 2,3,5-
triphenyltetrazolium chloride in saline- (Con, left)—and DS-treated mice (right). Mice were orally administered saline or 600mg/kg DS
twiceper dayfor3daysbeforetheischemicinsult.Miceweresubjected to90minofMCAOfollowedby22.5hofreperfusion. Whiteindicates
theinfarctarea.(b) Eﬀect ofDS oninfarct volumeinsaline-andL-NIO-treated miceat24h afterischemia.Infarction volumewascalculated
by an indirect measurement. DS signiﬁcantlyreduced cerebral infarct size; however, it did not aﬀect brain infarction in L-NIO-treated mice.
(c) Eﬀect of DS on ischemia and reperfusion induced impairment of motor coordination. DS markedly prevented ischemia-reperfusion
induced motor incoordination. Data are expressed as means ± SEM of six separate experiments. ∗P<. 05 versus control; ##P<. 01 versus
Sham group.
to an acute augmentation of CBF or other mechanisms
such as a direct neuroprotective action [14, 15]. Presently,
DS caused vasodilation and improved CBF, even it caused
mild hypotension. The endothelial and smooth muscle
mechanisms of vasodilation mediated by DS appear to be
diﬀerentially active in systemic and cerebral circulation.
Therefore, the direct smooth muscle relaxant eﬀect of DS
mildly decreased systemic resistance, butnot cerebrovascular
resistance. In light of the potential detrimental eﬀect of
systemic vasodilation and hyperemia on CBF in acute stroke,
DS may be more eﬃcacious in stroke therapy.
Therapies that restore CBF to ischemic regions are
eﬃcacious in acute stroke, suggesting that CBF is a critical
determinant of stroke outcome. NO constitutively produced
by eNOS regulates CBF and mediates vascular response and
protects against ischemic stroke by mediating vasodilation
and hence increases blood ﬂow to the damaged brain area
[3, 16, 17]. Several lines of evidence indicate that NO donor
orL-arginine improvesbloodﬂowandreducestissuedamage
after focal cerebral ischemia [18, 19]. Several therapeutic
modalities to upregulate and/or active eNOS might mediate
NO-dependent stroke-protective eﬀects [20]. The beneﬁcial
eﬀects of DS on ischemic injury are due at least in part to its
vascular protective actions, which involve eNOS-dependent
mechanisms, because the cerebroprotective actions of DS
are abolished in a relatively speciﬁc eNOS inhibitor [21],
L-NIO-treated mice. Consistent with these ﬁndings, Akt and
eNOS phosphorylation was presently increased in the brains
of DS-treated mice. Endothelial NO release is enhanced
through direct phosphorylation of eNOS by the protein
kinase Akt downstream of PI3K [22]. In contrast, total Akt,
eNOS, iNOS, and nNOS expression level did not diﬀer
between vehicle- and DS-treated mice. Together, the present
results clearly demonstrate that DS regulates eNOS signaling
to modulate vascular function under ischemic conditions,
protecting against cerebral injury after stroke.
DS represents a mixture of nine herbal medicines, con-
sisting of Angelicae gigantis Radix, Paeoniae Radix, Linderae
Radix,SappanLignum,CyperiRhizoma,CarthamiFlos,Per-
sicae Semen, Cinnamomi Cortex, and Glycyrrhizae Radix et
Rhizoma. Most traditional therapeutic formulations consist
of a combination of several drugs. Bioactivity from each
drugmaycollectivelyacttoblockmultipletargetsunderlying
ischemic pathophysiology, although little is known about
the mechanisms for their pharmacological activities [5, 6].
The combination of multiple drugs is thought to maximize
therapeutic eﬃcacy by facilitating synergistic actions and
preventing potential adverse eﬀects. However, little is known
concerning the compounds responsible for the protective
eﬀect of DS. It will be important to perform additional
experiments to identify the eﬃcient compounds from DS.
In summary, DS increases NO production, vasodilation
and improvement of CBF, which protects against cerebral
ischemia. The DS-mediated cerebroprotective eﬀects areEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Eﬀects of DS on phosphorylation of Akt and eNOS in
brain tissues. Phosphorylation of Akt (p-Akt) and eNOS (p-eNOS)
in braintissues ofsaline-(Con) andDS-treated miceat60min after
i s c h e m i a .A k t ,p - A k t ,e N O S ,p - e N O S ,i N O S ,a n dn N O Sp r o t e i n
levels were analyzedby Westernblotting(N = 4).DS promoted Akt
and eNOS phosphorylation in both ischemic (ipsilateral, Ipsil) and
nonischemic regions (contralateral, Cont) of the brain compared
with control.
absent in mice treated with a relatively speciﬁc eNOS
inhibitor, L-NIO, and eNOS phosphorylation is increased
in the brains of mice treated with DS, indicating the
obligatory role of endothelium-derived NO in mediating
these beneﬁcial eﬀects.
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